Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

actavis sdn. bhd. - drospirenone; ethinylestradiol -

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

actavis sdn. bhd. - drospirenone; ethinylestradiol -

Νέα Ζηλανδία - Αγγλικά - Ministry for Primary Industries

mavlab animal health limited - dexmedetomidine hydrochloride - dexmedetomidine hydrochloride 0.1 g/kg - behaviour modifier

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

getz healthcare pty ltd - 46352 - stent, vascular, intracranial - the leo+baby stent deployment system requires the use of: a self-expanding nitinol stent and a delivery system. the delivery system is comprised of a delivery wire an introducer and a torquer. the self-expanding stent is preloaded on the delivery wire inside the introducer. a reinforced catheter for placement and a y-connector with valve to enable the introducer to be positioned in contact with the hub of the micro catheter and for continuous flushing are not included in the leo+baby packaging. the self-expandable leo+baby stent is designed for the treatment of intracranial aneurysms in association with embolization coils and should be used only by clinicians trained in the placement of intracranial stents.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

leo pharma limited - calcipotriol 50 µg/g - topical cream - 50 mcg/g - active: calcipotriol 50 µg/g excipient: cetomacrogol 1000 cetostearyl alcohol dibasic sodium phosphate dihydrate disodium edetate dihydrate glycerol liquid paraffin n-(3-chloroallyl)hexaminium chloride purified water white soft paraffin

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

leo pharma limited - calcipotriol 50 µg/ml - topical solution - 50 mcg/g - active: calcipotriol 50 µg/ml excipient: hyprolose isopropyl alcohol levomenthol propylene glycol purified water sodium citrate dihydrate

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

leo pharma limited - sodium fusidate 250mg; sodium fusidate 250mg - film coated tablet - 250 mg - active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone gelatin hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc titanium dioxide active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone dl-alpha tocopheryl acetate hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - treatment of localised as well as generalised staphylococcal infections (e.g. abscesses, furunculosis, wound infections, pneumonia, peritonitis, osteomyelitis, septicaemia, enteritis and otorhinolaryngeal infections).

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

leo pharma limited - ingenol mebutate 0.015%{relative} ((70 µg per tube)) - topical gel - 0.015% w/w - active: ingenol mebutate 0.015%{relative} ((70 µg per tube)) excipient: benzyl alcohol citric acid monohydrate hyetellose isopropyl alcohol purified water sodium citrate dihydrate - topical treatment of solar (actinic) keratoses in adults

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

leo pharma limited - ingenol mebutate 0.05%{relative} ((235 µg per tube)) - topical gel - 0.05% w/w - active: ingenol mebutate 0.05%{relative} ((235 µg per tube)) excipient: benzyl alcohol citric acid monohydrate hyetellose isopropyl alcohol purified water sodium citrate dihydrate - topical treatment of solar (actinic) keratoses in adults

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

leo pharma asia pte ltd - tinzaparin sodium - injection - 10,000 axa iu/ml - tinzaparin sodium 10,000 axa iu/ml